Editorial: Considerations of risks versus benefits.
An evaluation of risks versus benefits from new products should be encouraged, even when dealing with agents which may cause cancer or malformations in laboratory animals, because there is evidence that safety thresholds exist even for such exposures. However, it is not easy to describe risk and benefit in comparable terms when they may involve generations to come and events in the future.
D000818:Animals; D002273:Carcinogens / Q000633:toxicity; D003362:Cost-Benefit Analysis; D004357:Drug Synergism; D004781:Environmental Exposure; D004782:Environmental Health; D005069:Evaluation Studies as Topic; D006801:Humans; D009153:Mutagens / Q000633:toxicity; D012306:Risk; D014116:Toxicology
D002273:Carcinogens; D009153:Mutagens